IBDEI0KI ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27730,1,3,0)
 ;;=3^Solar Retinopathy
 ;;^UTILITY(U,$J,358.3,27730,1,4,0)
 ;;=4^363.31
 ;;^UTILITY(U,$J,358.3,27730,2)
 ;;=Solar Retinopathy^265207
 ;;^UTILITY(U,$J,358.3,27731,0)
 ;;=363.32^^155^1747^56
 ;;^UTILITY(U,$J,358.3,27731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27731,1,3,0)
 ;;=3^Macular Scars
 ;;^UTILITY(U,$J,358.3,27731,1,4,0)
 ;;=4^363.32
 ;;^UTILITY(U,$J,358.3,27731,2)
 ;;=Macular Scars^268680
 ;;^UTILITY(U,$J,358.3,27732,0)
 ;;=362.83^^155^1747^53
 ;;^UTILITY(U,$J,358.3,27732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27732,1,3,0)
 ;;=3^Macular Edema (Csme)
 ;;^UTILITY(U,$J,358.3,27732,1,4,0)
 ;;=4^362.83
 ;;^UTILITY(U,$J,358.3,27732,2)
 ;;=Macular Edema (CSME)^89576
 ;;^UTILITY(U,$J,358.3,27733,0)
 ;;=362.84^^155^1747^87
 ;;^UTILITY(U,$J,358.3,27733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27733,1,3,0)
 ;;=3^Retinal Ischemia
 ;;^UTILITY(U,$J,358.3,27733,1,4,0)
 ;;=4^362.84
 ;;^UTILITY(U,$J,358.3,27733,2)
 ;;=Retinal Ischemia^276868
 ;;^UTILITY(U,$J,358.3,27734,0)
 ;;=363.20^^155^1747^14
 ;;^UTILITY(U,$J,358.3,27734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27734,1,3,0)
 ;;=3^Chorioretinitis
 ;;^UTILITY(U,$J,358.3,27734,1,4,0)
 ;;=4^363.20
 ;;^UTILITY(U,$J,358.3,27734,2)
 ;;=Chorioretinitis^23913
 ;;^UTILITY(U,$J,358.3,27735,0)
 ;;=115.92^^155^1747^43
 ;;^UTILITY(U,$J,358.3,27735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27735,1,3,0)
 ;;=3^Histoplamosis (Pohs)
 ;;^UTILITY(U,$J,358.3,27735,1,4,0)
 ;;=4^115.92
 ;;^UTILITY(U,$J,358.3,27735,2)
 ;;=Histoplamosis Retinitis^266905
 ;;^UTILITY(U,$J,358.3,27736,0)
 ;;=363.70^^155^1747^15
 ;;^UTILITY(U,$J,358.3,27736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27736,1,3,0)
 ;;=3^Choroidal Detachment
 ;;^UTILITY(U,$J,358.3,27736,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,27736,2)
 ;;=Choroidal Detachment^276841
 ;;^UTILITY(U,$J,358.3,27737,0)
 ;;=363.63^^155^1747^19
 ;;^UTILITY(U,$J,358.3,27737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27737,1,3,0)
 ;;=3^Choroidal Rupture
 ;;^UTILITY(U,$J,358.3,27737,1,4,0)
 ;;=4^363.63
 ;;^UTILITY(U,$J,358.3,27737,2)
 ;;=Choroidal Rupture^268698
 ;;^UTILITY(U,$J,358.3,27738,0)
 ;;=379.22^^155^1747^5
 ;;^UTILITY(U,$J,358.3,27738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27738,1,3,0)
 ;;=3^Asteroid Hyalosis
 ;;^UTILITY(U,$J,358.3,27738,1,4,0)
 ;;=4^379.22
 ;;^UTILITY(U,$J,358.3,27738,2)
 ;;=Asteroid Hyalosis^269310
 ;;^UTILITY(U,$J,358.3,27739,0)
 ;;=379.21^^155^1747^104
 ;;^UTILITY(U,$J,358.3,27739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27739,1,3,0)
 ;;=3^Vitreous Detachment/Degeneration (Pvd)
 ;;^UTILITY(U,$J,358.3,27739,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,27739,2)
 ;;=Vitreous Detachment/Degeneration^88242
 ;;^UTILITY(U,$J,358.3,27740,0)
 ;;=379.24^^155^1747^105
 ;;^UTILITY(U,$J,358.3,27740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27740,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,27740,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,27740,2)
 ;;=Vitreous Floaters^88242
 ;;^UTILITY(U,$J,358.3,27741,0)
 ;;=379.26^^155^1747^107
 ;;^UTILITY(U,$J,358.3,27741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27741,1,3,0)
 ;;=3^Vitreous Prolapse
 ;;^UTILITY(U,$J,358.3,27741,1,4,0)
 ;;=4^379.26
 ;;^UTILITY(U,$J,358.3,27741,2)
 ;;=Vitreous Prolapse^269312
 ;;^UTILITY(U,$J,358.3,27742,0)
 ;;=379.23^^155^1747^106
 ;;^UTILITY(U,$J,358.3,27742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27742,1,3,0)
 ;;=3^Vitreous Hemorrhage
 ;;^UTILITY(U,$J,358.3,27742,1,4,0)
 ;;=4^379.23
 ;;^UTILITY(U,$J,358.3,27742,2)
 ;;=Vitreous Hemorrhage^127096
 ;;^UTILITY(U,$J,358.3,27743,0)
 ;;=362.18^^155^1747^89
 ;;^UTILITY(U,$J,358.3,27743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27743,1,3,0)
 ;;=3^Retinal Vasculitis
 ;;^UTILITY(U,$J,358.3,27743,1,4,0)
 ;;=4^362.18
 ;;^UTILITY(U,$J,358.3,27743,2)
 ;;=Retinal Vasculitis^264463
 ;;^UTILITY(U,$J,358.3,27744,0)
 ;;=360.21^^155^1747^31
 ;;^UTILITY(U,$J,358.3,27744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27744,1,3,0)
 ;;=3^Degenerative Myopia
 ;;^UTILITY(U,$J,358.3,27744,1,4,0)
 ;;=4^360.21
 ;;^UTILITY(U,$J,358.3,27744,2)
 ;;=Degenerative Myopia^268553
 ;;^UTILITY(U,$J,358.3,27745,0)
 ;;=362.64^^155^1747^80
 ;;^UTILITY(U,$J,358.3,27745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27745,1,3,0)
 ;;=3^Reticular Degeneration
 ;;^UTILITY(U,$J,358.3,27745,1,4,0)
 ;;=4^362.64
 ;;^UTILITY(U,$J,358.3,27745,2)
 ;;=Reticular Degeneration^268645
 ;;^UTILITY(U,$J,358.3,27746,0)
 ;;=362.61^^155^1747^29
 ;;^UTILITY(U,$J,358.3,27746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27746,1,3,0)
 ;;=3^Degeneration, Paving Stone
 ;;^UTILITY(U,$J,358.3,27746,1,4,0)
 ;;=4^362.61
 ;;^UTILITY(U,$J,358.3,27746,2)
 ;;=Paving Stone Degeneration^268642
 ;;^UTILITY(U,$J,358.3,27747,0)
 ;;=362.42^^155^1747^94
 ;;^UTILITY(U,$J,358.3,27747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27747,1,3,0)
 ;;=3^Rpe Detachment, Serous
 ;;^UTILITY(U,$J,358.3,27747,1,4,0)
 ;;=4^362.42
 ;;^UTILITY(U,$J,358.3,27747,2)
 ;;=Serous RPE Detachment^268633
 ;;^UTILITY(U,$J,358.3,27748,0)
 ;;=362.43^^155^1747^93
 ;;^UTILITY(U,$J,358.3,27748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27748,1,3,0)
 ;;=3^Rpe Detachment, Hemorrhagic
 ;;^UTILITY(U,$J,358.3,27748,1,4,0)
 ;;=4^362.43
 ;;^UTILITY(U,$J,358.3,27748,2)
 ;;=Hemorrhagic RPE Detachment^268634
 ;;^UTILITY(U,$J,358.3,27749,0)
 ;;=250.00^^155^1747^34
 ;;^UTILITY(U,$J,358.3,27749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27749,1,3,0)
 ;;=3^Dm Type II, No Retinopathy
 ;;^UTILITY(U,$J,358.3,27749,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,27749,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,27750,0)
 ;;=250.01^^155^1747^33
 ;;^UTILITY(U,$J,358.3,27750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27750,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,27750,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,27750,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,27751,0)
 ;;=250.50^^155^1747^25
 ;;^UTILITY(U,$J,358.3,27751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27751,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,27751,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,27751,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,27752,0)
 ;;=250.51^^155^1747^27
 ;;^UTILITY(U,$J,358.3,27752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27752,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,27752,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,27752,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,27753,0)
 ;;=362.01^^155^1747^32
 ;;^UTILITY(U,$J,358.3,27753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27753,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,27753,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,27753,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,27754,0)
 ;;=362.02^^155^1747^72
 ;;^UTILITY(U,$J,358.3,27754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27754,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,27754,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,27754,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,27755,0)
 ;;=362.03^^155^1747^64
 ;;^UTILITY(U,$J,358.3,27755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27755,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,27755,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,27755,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,27756,0)
 ;;=362.04^^155^1747^61
 ;;^UTILITY(U,$J,358.3,27756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27756,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,27756,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,27756,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,27757,0)
 ;;=362.05^^155^1747^62
 ;;^UTILITY(U,$J,358.3,27757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27757,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,27757,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,27757,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,27758,0)
 ;;=362.06^^155^1747^98
 ;;^UTILITY(U,$J,358.3,27758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27758,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,27758,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,27758,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,27759,0)
 ;;=379.27^^155^1747^103
 ;;^UTILITY(U,$J,358.3,27759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27759,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,27759,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,27759,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,27760,0)
 ;;=115.02^^155^1747^44
 ;;^UTILITY(U,$J,358.3,27760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27760,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,27760,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,27760,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,27761,0)
 ;;=190.5^^155^1747^58
 ;;^UTILITY(U,$J,358.3,27761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27761,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,27761,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,27761,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,27762,0)
 ;;=198.4^^155^1747^59
 ;;^UTILITY(U,$J,358.3,27762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27762,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,27762,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,27762,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,27763,0)
 ;;=200.00^^155^1747^81
 ;;^UTILITY(U,$J,358.3,27763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27763,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,27763,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,27763,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,27764,0)
 ;;=228.03^^155^1747^38
 ;;^UTILITY(U,$J,358.3,27764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27764,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,27764,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,27764,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,27765,0)
 ;;=228.09^^155^1747^39
 ;;^UTILITY(U,$J,358.3,27765,1,0)
 ;;=^358.31IA^4^2
